CTBP2 and prostate carcinoma: The c-terminal binding protein-2 (CTBP2) is a highly conserved transcriptional co-repressor that has been reported to be involved in the development and progression of several human cancers and associated with the poor prognosis of prostate cancer and lung cancer [13–15].